The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent
Open accessAbstract
Metastasis is the primary cause of death in breast cancer patients. Early detection of high-risk breast cancer, including micrometastasis, is critical in tailoring appropriate and effective interventional therapies. Increased fibronectin expression, a hallmark of epithelial-to-mesenchymal transition, is associated with high-risk breast cancer and metastasis. We have previously developed a penta-peptide CREKA (Cys-Arg-Glu-Lys-Ala)-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agent, CREKA-Tris(Gd-DOTA)3 (Gd-DOTA (4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecyl gadolinium), which binds to fibrin–fibronectin complexes that are abundant in the tumour microenvironment of fast-growing breast cancer. Here we assess the capability of CREKA-Tris(Gd-DOTA)3 to detect micrometastasis with MRI in co-registration with high-resolution fluorescence cryo-imaging in female mice bearing metastatic 4T1 breast tumours. We find that CREKA-Tris(Gd-DOTA)3 provides robust contrast enhancement in the metastatic tumours and enables the detection of micrometastases of size <0.5 mm, extending the detection limit of the current clinical imaging modalities. These results demonstrate that molecular MRI with CREKA-Tris(Gd-DOTA)3 may facilitate early detection of high-risk breast cancer and micrometastasis in the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
A Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
Caravan, P., Ellison, J. J., McMurry, T. J., & Lauffer, R. B. (1999) · Chemical Reviews · doi:10.1021/cr980440x · Cited by 4,483
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024
Metastatic Behavior of Breast Cancer Subtypes
Kennecke, H., Yerushalmi, R., Woods, R., Cheang, M. C. U., Voduc, D., Speers, C. H., Nielsen, T. O., & Gelmon, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9820 · Cited by 2,262
Breast cancer metastasis: markers and models
Weigelt, B., Peterse, J. L., & van't Veer, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1670 · Cited by 2,232
Metastasis: a question of life or death
Mehlen, P., & Puisieux, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1886 · Cited by 1,863
Genomic analysis of metastasis reveals an essential role for RhoC
Clark, E. A., Golub, T. R., Lander, E. S., & Hynes, R. O. (2000) · Nature · doi:10.1038/35020106 · Cited by 1,445
The clinical course of bone metastases from breast cancer
Coleman, R., & Rubens, R. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.13 · Cited by 1,084
Pulaski, B. A., & Ostrand‐Rosenberg, S. (2000) · Current Protocols in Immunology · doi:10.1002/0471142735.im2002s39 · Cited by 912
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. P. (1998) · Nature Medicine · doi:10.1038/nm0598-623 · Cited by 850
Targeting of drugs and nanoparticles to tumors
Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910104 · Cited by 829
Lee, C. H., Dershaw, D. D., Kopans, D., Evans, P., Monsees, B., Monticciolo, D., Brenner, R. J., Bassett, L., Berg, W., Feig, S., et al. (2010) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2009.09.022 · Cited by 809
(2001) · Radiology · doi:10.1148/radiology.220.2.r01au28372 · Cited by 716
Preparing the “Soil”: The Premetastatic Niche
Kaplan, R. N., Rafii, S., & Lyden, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2407 · Cited by 665
Kawamoto, T. (2003) · Archives of Histology and Cytology · doi:10.1679/aohc.66.123 · Cited by 618
Biomimetic amplification of nanoparticle homing to tumors
Simberg, D., Duza, T., Park, J. H., Essler, M., Pilch, J., Zhang, L., Derfus, A. M., Yang, M., Hoffman, R. M., Bhatia, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610298104 · Cited by 471
Khanna, C. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh261 · Cited by 463
Gadolinium‐based contrast agents for magnetic resonance cancer imaging
Zhou, Z., & Lu, Z. (2013) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1198 · Cited by 427
Self-citationThe pre-metastatic niche: finding common ground
Sceneay, J., Smyth, M. J., & Möller, A. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9420-1 · Cited by 422
Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth
Barkan, D., Green, J. E., & Chambers, A. F. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.027 · Cited by 377
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Langley, R. R., & Fidler, I. J. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0027 · Cited by 373
Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
Thomsen, H. S. (2006) · European Radiology · doi:10.1007/s00330-006-0495-8 · Cited by 352
Breast Cancer Metastasis: Challenges and Opportunities
Lu, J., Steeg, P. S., Price, J. E., Krishnamurthy, S., Mani, S. A., Reuben, J., Cristofanilli, M., Dontu, G., Bidaut, L., Valero, V., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0099 · Cited by 251
Doerner, A. M., & Zuraw, B. L. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-100 · Cited by 234
Increased β1 Integrin Is Associated with Decreased Survival in Invasive Breast Cancer
Yao, E. S., Zhang, H., Chen, Y.-Y., Lee, B., Chew, K., Moore, D., & Park, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2768 · Cited by 227
The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases
Rybak, J.-N., Roesli, C., Kaspar, M., Villa, A., & Neri, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1436 · Cited by 212
Reticker-Flynn, N. E., Malta, D. F. B., Winslow, M. M., Lamar, J. M., Xu, M. J., Underhill, G. H., Hynes, R. O., Jacks, T. E., & Bhatia, S. N. (2012) · Nature Communications · doi:10.1038/ncomms2128 · Cited by 195
Automated region detection based on the contrast-to-noise ratio in near-infrared tomography
Song, X., Pogue, B. W., Jiang, S., Doyley, M. M., Dehghani, H., Tosteson, T. D., & Paulsen, K. D. (2004) · Applied Optics · doi:10.1364/ao.43.001053 · Cited by 195
The relevance of the TGF-β Paradox to EMT-MET programs
Morrison, C. D., Parvani, J. G., & Schiemann, W. P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.048 · Cited by 183
Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling
Zhou, F., Drabsch, Y., Dekker, T. J. A., de Vinuesa, A. G., Li, Y., Hawinkels, L. J. A. C., Sheppard, K.-A., Goumans, M.-J., Luwor, R. B., de Vries, C. J., et al. (2014) · Nature Communications · doi:10.1038/ncomms4388 · Cited by 180
Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds
Pilch, J., Brown, D. M., Komatsu, M., Järvinen, T. A. H., Yang, M., Peters, D., Hoffman, R. M., & Ruoslahti, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511219103 · Cited by 162
Parvani, J. G., Gujrati, M. D., Mack, M. A., Schiemann, W. P., & Lu, Z.-R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3485 · Cited by 159
Self-citationFernández‐García, B., Eiró, N., Marín, L., González‐Reyes, S., González, L. O., Lamelas, M. L., & Vizoso, F. J. (2013) · Histopathology · doi:10.1111/his.12300 · Cited by 159
Antibody-Radionuclide Conjugates for Cancer Therapy: Historical Considerations and New Trends
Steiner, M., & Neri, D. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0483 · Cited by 157
Molecular MRI enables early and sensitive detection of brain metastases
Serres, S., Soto, M. S., Hamilton, A., McAteer, M. A., Carbonell, W. S., Robson, M. D., Ansorge, O., Khrapitchev, A. A., Bristow, C., Balathasan, L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117412109 · Cited by 148
Obberghen‐Schilling, E. V., Tucker, R. P., Saupe, F., Gasser, I., Cseh, B., & Orend, G. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103243eo · Cited by 144
Plasma Fibronectin Promotes Lung Metastasis by Contributions to Fibrin Clots and Tumor Cell Invasion
Malik, G., Knowles, L. M., Dhir, R., Xu, S., Yang, S., Ruoslahti, E. I., & Pilch, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3312 · Cited by 144
Rebuilding cancer metastasis in the mouse
Saxena, M. T., & Christofori, G. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.009 · Cited by 139
Imaging Metastasis Using an Integrin-Targeting Chain-Shaped Nanoparticle
Peiris, P. M., Toy, R., Doolittle, E., Pansky, J., Abramowski, A., Tam, M., Vicente, P., Tran, E., Hayden, E., Camann, A., et al. (2012) · ACS Nano · doi:10.1021/nn303833p · Cited by 138
Self-citationHemmerle, T., Probst, P., Giovannoni, L., Green, A. J., Meyer, T., & Neri, D. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.421 · Cited by 87
Tan, M., Wu, X., Jeong, E., Chen, Q., & Lu, Z. (2010) · Biomacromolecules · doi:10.1021/bm901352v · Cited by 83
Self-citationPeptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI
Zhou, Z., Wu, X., Kresak, A. M., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.057 · Cited by 82
Self-citationCirculating Fibronectin Controls Tumor Growth
von Au, A., Vasel, M., Kraft, S., Sens, C., Hackl, N., Marx, A., Ströbel, P., Hennenlotter, J., Todenhöfer, T., Stenzl, A., et al. (2013) · Neoplasia · doi:10.1593/neo.13762 · Cited by 79
Wendt, M. K., Taylor, M. A., Schiemann, B. J., Sossey‐Alaoui, K., & Schiemann, W. P. (2014) · Breast Cancer Research · doi:10.1186/bcr3623 · Cited by 72
Zhou, Z., & Lu, Z. (2014) · Nanomedicine · doi:10.2217/nnm.14.133 · Cited by 57
Self-citationBurden‐Gulley, S. M., Qutaish, M. Q., Sullivant, K. E., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1553 · Cited by 51
Self-citationMolecular Imaging of Fibrin in a Breast Cancer Xenograft Mouse Model
Uppal, R., Medarova, Z. O., Farrar, C. T., Dai, G., Moore, A. V., & Caravan, P. D. (2012) · Investigative Radiology · doi:10.1097/rli.0b013e31825dddfb · Cited by 34
Cited by
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
Wahsner, J., Gale, E. M., Rodríguez-Rodríguez, A., & Caravan, P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00363 · Cited by 1,603
Theranostic Fluorescent Probes
Sharma, A., Verwilst, P., Li, M., Ma, D., Singh, N., Yoo, J., Kim, Y., Yang, Y., Zhu, J.-H., Huang, H., et al. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00778 · Cited by 499
Radiomics in breast cancer classification and prediction
Conti, A., Duggento, A., Indovina, I., Guerrisi, M., & Toschi, N. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.04.002 · Cited by 386
A framework for the development of effective anti-metastatic agents
Anderson, R. L., Balasas, T., Callaghan, J., Coombes, R. C., Evans, J., Hall, J. A., Kinrade, S., Jones, D., Jones, P. S., Jones, R., et al. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0134-8 · Cited by 341
Systemic Review of Biodegradable Nanomaterials in Nanomedicine
Su, S., & Kang, P. M. (2020) · Nanomaterials · doi:10.3390/nano10040656 · Cited by 312
Metadata
- Authors
- Zhou, Z., Qutaish, M., Han, Z., Schur, R. M., Liu, Y., Wilson, D. L., & Lu, Z.-R.
- Venue
- Nature Communications
- Published
- 2015-08-12
- Volume
- 6
- Issue
- 1
- Pages
- 7984-7984
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W1202879735
- Cited by
- 260
- References
- 49
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.